Valuation: Lead Data Inc.

Market Cap 539M 16.62M 14.53M 13.41M 12.36M 23.29M 1.6B 23.81M 160M 63.03M 784M 62.43M 61.06M 2.7B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.52M 15.31M 14.13M 13.03M 24.55M 1.69B 25.1M 169M 66.43M 826M 65.81M 64.37M 2.85B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 16/08/2022
Director of Finance/CFO - 09/06/2022
Corporate Officer/Principal - 09/06/2022
Director TitleAgeSince
Director/Board Member - 09/06/2019
Chairman - 16/08/2022
Director/Board Member - 09/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+2.88% 16.62M
-0.50%+4.05%+27.09%+10.83% 10B
-7.34%+7.59% - - 1.37B
+1.32%+3.62%+15.01%+3.25% 1.33B
+0.93%+2.73%+4.17%-9.48% 1.09B
-9.96%-3.64%+44.60%+24.97% 605M
-3.44%+2.47%-21.25%-52.04% 600M
0.00%+0.58%+111.95%+157.86% 416M
-1.81%+1.29%-12.25%-14.39% 411M
-8.20%+1.46%-55.23%-81.88% 266M
Average -3.88%-0.45%+12.68%+4.67% 1.61B
Weighted average by Cap. -1.46%+3.31%+22.84%+8.43%

Financials

2024 2025
Net sales 15.47M 477K 417K 385K 355K 669K 45.96M 683K 4.6M 1.81M 22.51M 1.79M 1.75M 77.49M 111M 3.42M 2.98M 2.75M 2.54M 4.79M 329M 4.89M 32.92M 12.95M 161M 12.83M 12.55M 555M
Net income -134M -4.13M -3.61M -3.33M -3.07M -5.78M -398M -5.91M -39.79M -15.65M -195M -15.5M -15.16M -670M -44.02M -1.36M -1.19M -1.1M -1.01M -1.9M -131M -1.95M -13.09M -5.15M -64.07M -5.1M -4.99M -221M
Net Debt -16.95M -523K -457K -422K -389K -733K -50.38M -749K -5.04M -1.98M -24.67M -1.96M -1.92M -84.94M 29.12M 899K 785K 725K 668K 1.26M 86.53M 1.29M 8.66M 3.41M 42.38M 3.37M 3.3M 146M
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock